SOR-C13 TFA

SOR-C13 TFA, an extraordinary and highly specialized inhibitor deployed within the biomedical sphere for the purpose of combating cancer, embodies immense potency. Notably designed to single out sorafenib-resistant cells, it amplifies the efficacy of the widely employed sorafenib drug, primarily acclaimed for its profound impact against advanced renal cell carcinoma and liver malignancies.

Online Inquiry

CAT#R2011
M.F/FormulaC74H117F3N20O21
M.W/Mr.1679.84
AppearanceSolid
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

of skin aging Skin aging is the obvious external manifestation of a natural process occurring in tissues and or ...

 Galanin-(2–13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide (M871) is a novel peptide antagonist selectively recognizing ...

 Nafarelin acetate is a gonadotropin-releasing hormone (GnRH) agonist which is as effective as danazol in the tre ...

  Pergolide mesylate salt , also known as 8-beta-((methylthio)methyl)-D-6-propylergoline methanesulfonate, is a ...

 GsMTx4 is a synthetic and biologically active peptide toxin. Its molecular formula is C185H273N49O45S6, with the ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.